Qualitative differences in disease-associated MEK mutants reveal molecular signatures and aberrant signaling-crosstalk in cancer

Yuji Kubota(The University of Tokyo), Mutsuhiro Takekawa(Institute for Advanced Medical Research)
Nature Communications
July 13, 2022
Cited by 21


Related Papers